Answers are grounded in this paper and cite their sources.
We report the results of studies related to the fabrication of a palladium nanoparticle decorated-reduced graphene oxide (Pd@rGO) based electrochemical immunosensor for the label free ultrasensitive detection of the prostate-specific antigen (PSA), a prostate cancer biomarker.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: